Skip to main content

Advertisement

Table 1 General characteristics of the patients

From: The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial

  Group  
  n-3 PUFAs (n = 36) Placebo (n = 35) P value
Gender (%)    
 Male 50 60  
 Female 50 40 .477*
Age (Year, mean ± SD) 54.14 ± 10.53 53.40 ± 15.70 .816**
 Male 58.22 ± 8.02 54.48 ± 16.56  
 Female 50.06 ± 11.34 51.79 ± 14.78  
BMIa (kg/m2,mean ± SD) 23.47 ± 3.40 23.22 ± 4.77 .806**
 Male 22.43 ± 2.94 22.26 ± 2.91  
 Female 24.54 ± 4.68 24.91 ± 6.77  
  1. *P value is reported based on exact Chi-square test
  2. **P value is reported based on Independent-Samples T Test
  3. aBody mass index